期刊
CANCER LETTERS
卷 492, 期 -, 页码 96-105出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.08.018
关键词
AML; Vitamin B6; Monocytes; Apoptosis; Pyroptosis
类别
资金
- National Science and Technology Major Project of China [2016ZX08011-005]
- Key Scientific Research Projects of University in Guangdong Province [2018KZDXM057]
- National Natural Science Foundation of China [81871266]
- Scientific Research Project of Guangzhou Municipal Government [201804020042]
- 111 Project [D18010]
Acute myeloid leukemia (AML) is an aggressive hematological malignancy that gradually develops resistance to current chemotherapy treatments. The available chemotherapy drugs show serious non-specific cytotoxicity to healthy normal cells, resulting in relapse and low survival rates. Natural small molecules with less toxicity and high selectivity for AML are urgently needed. In this study, we confirmed that pyridoxine (vitamin B6) selectively induces monocyte macrophages to undergo programmed cell death in two different modes: caspase-3-dependent apoptosis in U937 cells or GSDME-mediated pyroptosis in THP-1 cells. Further molecular analysis indicated that blocking the caspase pathway could switch the death to MLKL-dependent necroptosis and subsequent extensive inflammatory response. Pyridoxine also delayed the disease progression in a THP-1 leukemia mouse model. In addition, it induced the death of primary AML cells from AML patients by activating caspase-8/3. Overall, our results identify pyridoxine, a low-toxicity natural small molecule, as a potential therapeutic drug for AML treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据